The China liver cancer drug market size was valued at USD 209.91 million in 2023 and is projected to grow at a CAGR of 20.6% from 2024 to 2030, driven by the increasing incidence of the disease, advancements in treatment modalities, growing awareness, and early diagnostic practices in th... Read More »
September 2024The global general anesthesia drugs market size was estimated at USD 5.1 billion in 2023 and is projected to grow at a CAGR of 3.7% from 2024 to 2030. This growth is primarily fueled by the increasing volume of surgical procedures, advancements in anesthesia technology, and the rising pr... Read More »
September 2024The U.S. general anesthesia drugs market size was estimated at USD 1.67 billion in 2023 and is projected to grow at a CAGR of 2.8% from 2024 to 2030. This growth is fueled by several key factors, including a rising number of surgical procedures, technological advancements in anesthesia, ... Read More »
September 2024The global acne drugs market size was valued at USD 9.22 billion in 2023 and is projected to grow at a CAGR of 5.2% from 2024 to 2030. The driving factors of the growth include the increasing prevalence of acne, lifestyle changes, rising skin awareness, and growing cosmetic concerns. Acn... Read More »
September 2024The North America topical skin treatment market size was estimated at USD 6.64 billion in 2023 and is projected to grow at a CAGR of 9.60% from 2024 to 2030. The market growth can be attributed to the increasing prevalence of skin conditions, advancements in treatment options, and strate... Read More »
September 2024The global cerebral infarction treatment market size was estimated at USD 12.4 billion in 2023 and is projected to grow at a CAGR of 7.3% from 2024 to 2030. This growth is driven by rising prevalence of cerebrovascular diseases, advancements in medical technology, increased healthcare sp... Read More »
September 2024The China lung cancer therapeutics market size is estimated at USD 2.18 billion in 2023 and is projected to grow at a CAGR of 13.7% from 2024 to 2030. The increasing incidence of lung cancer, growing awareness and screening initiatives, and adoption of targeted therapies in the country, ... Read More »
September 2024The global contraceptive drugs and devices market size was valued at USD 29.6 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. The market growth can be attributed to an increase in the number of sexually transmitted diseases (STDs) and unintended pregnancies.... Read More »
September 2024The Middle East & Africa parenteral nutrition market size was valued at USD 256.5 million in 2023 and is projected to grow at a CAGR of 4.4% from 2024 to 2030. The increase in the geriatric population and the growing prevalence of chronic diseases and gastrointestinal disorders are t... Read More »
September 2024The global thalassemia market size was valued at USD 850.0 million in 2023 and it is projected to grow at a CAGR of 7.8% from 2024 to 2030. This growth can be attributed to rising awareness about thalassemia and the importance of proper management, advancement in medical technology, risi... Read More »
September 2024The global pediatric diabetes therapeutic market size was estimated at USD 8.92 billion in 2023 and is projected to grow at a CAGR of 13.9% from 2024 to 2030. This growth can be attributed to a combination of rising incidence rates of diabetes among children and adolescents, advancements... Read More »
September 2024The global NUT midline carcinoma treatment market size was estimated at USD 19.4 billion in 2023 and is projected to grow at a CAGR of 12.4% from 2024 to 2030. This growth is driven by a rising prevalence of the NUT midline carcinoma, advancements in diagnostics and therapeutics, regulat... Read More »
September 2024The global epithelioma treatment market size was estimated at USD 4.85 billion in 2023 and is projected to grow at a CAGR of 10.4% from 2024 to 2030. This growth is driven by the rising incidence of skin cancers, continuous advancements in therapeutic options, increased public awareness ... Read More »
September 2024The global primary immunodeficiency disorders market size was valued at USD 7.15 billion in 2023 and is projected to grow at a CAGR of 6.4% from 2024 to 2030. The market is experiencing significant growth due to several factors. The rising incidence of PID, coupled with greater awareness... Read More »
September 2024The global invasive ductal carcinoma treatment market size was valued at USD 8.59 billion in 2023 and is projected to grow at a CAGR of 8.50% from 2024 to 2030. The rising prevalence of breast cancer, technological advancements, an increasing preference for personalized medicine, governm... Read More »
September 2024The global duodenal ulcer treatment market size was estimated at USD 4.45 billion in 2023 and is projected to grow at a CAGR of 3.18% from 2024 to 2030. The market is driven by a combination of factors, including the rising prevalence of duodenal ulcers, advancements in treatment options... Read More »
September 2024The global pharmerging market size was valued at USD 1.73 trillion in 2023 and is projected to grow at a CAGR of 2.6% from 2024 to 2030. This growth is attributed to the growing requirement for affordable generics. In addition, government policies that promote localization are expected t... Read More »
September 2024The global superdisintegrants market size was valued at USD 536.2 million in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. This growth is attributed to several factors, including the expansion of the generics market, which heavily utilizes orally disintegrating... Read More »
August 2024The global acute lymphocytic leukemia therapeutics market size was valued at USD 3.12 billion in 2023 and is projected to grow at a CAGR of 7.0% from 2024 to 2030. The acute lymphocytic leukemia therapeutics market is expected to grow due to the increasing rate of the condition in the yo... Read More »
August 2024The global doxorubicin market size was valued at USD 989.6 million in 2023 and is projected to grow at a CAGR of 6.6% from 2024 to 2030. Doxorubicin, a potent chemotherapy drug in the anthracycline class, has established a significant presence in the global pharmaceutical market. Its wid... Read More »
August 2024